Midjourney Builds a Body Scanner It Says Beats the MRI on Cost and Speed

    The AI image company launched Midjourney Medical and a full-body ultrasonic scanner promising a 60-second scan, though the prototype still takes 20 minutes and has no FDA clearance.

    Midjourney Builds a Body Scanner It Says Beats the MRI on Cost and Speed The AI image company launched Midjourney Medical and a full-body ultrasonic scanner promising a 60-second scan, though the prototype still takes 20 minutes and has no FDA clearance. Aaron Rafferty June 19, 2026 Key Takeaways Midjourney launched a medical division and the Midjourney Scanner on June 17, a full-body ultrasonic device built on Butterfly Network chips. The company claims a 60-second scan at a fraction of an MRI's cost, with a goal of 50,000 scanners worldwide by 2031. The current prototype takes about 20 minutes, has scanned roughly a dozen people, uses no AI yet, and carries no FDA clearance. Midjourney, the company best known for turning text prompts into images, announced a medical division on June 17 and a first hardware product called the Midjourney Scanner. Engadget reported the device is designed to scan a whole body in about 60 seconds, and the company is building spas where people can step in and get scanned. The Scanner is a full-body ultrasonic imaging system, not an MRI. The Register reported that ultrasound firm Butterfly Network supplied the 40 imaging modules under a co-development license, and that the device captures tissue detail down to about half a millimeter, close to a clinical MRI. Midjourney's pitch is cost and access. CEO David Holz says a scan will eventually take 60 seconds and cost a fraction of an MRI's price, with a goal of 50,000 scanners worldwide by 2031 to bring full-body imaging to everyone. The Prototype Is Years Behind the Pitch The gap between the announcement and the hardware is wide. TechTimes reported the current prototype takes roughly 20 minutes per scan, has been used on about a dozen people, runs with no AI in its imaging pipeline

    Loading full article…